Horning Sandra — SEC Form 4 filings
SEC reporting owner CIK 1638709. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-05-07 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | Director | 4 | — | — | 9 |
| Revolution Medicines, Inc. (RVMD) | Director | 4 | — | — | 8 |
| GILEAD SCIENCES, INC. (GILD) | Director | 3 | — | — | 6 |
| Olema Pharmaceuticals, Inc. (OLMA) | Director | 3 | — | — | 3 |
Form 4 filings — Horning Sandra
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 29,500 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 9,681 (derivative) @ $0 · Grant/award (A): 2,092 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 1,146 @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 16,233 · Option exercise (M): 16,233 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 3,142 @ $0 · Grant/award (A): 11,574 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 24,150 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 1,516 @ $0 · Grant/award (A): 6,809 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 979 · Option exercise (M): 979 (derivative) @ $0 · Grant/award (A): 16,233 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4/A | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 2,945 @ $0 · Grant/award (A): 10,248 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 4,800 @ $0 · Grant/award (A): 16,700 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 2,310 (derivative) · Grant/award (A): 12,648 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 5,668 (derivative) @ $0 · Grant/award (A): 979 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1638709 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →